Dermatomyositis

Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2
Sheng-Xiao Zhang, Jia Wang, He-Hua Sun, Jia-Qian Zhang, Guang-Ying Liu, Jing Luo, Pei-Feng He, Xiao-Feng Li

Annals of the Rheumatic Diseases Aug 2021, 80 (8) e130; DOI: 10.1136/annrheumdis-2019-216246
Standardisation of myositis-specific antibodies: where are we today?
Michael Mahler, Jean-Baptiste Vulsteke, Xavier Bossuyt, Ellen De Langhe, Minoru Satoh

Annals of the Rheumatic Diseases Aug 2021, 80 (8) e132; DOI: 10.1136/annrheumdis-2019-216003
Response to: ‘Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis’ by Campochiaro et al
Lionel Spielmann, François Séverac, Alain Meyer

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e114; DOI: 10.1136/annrheumdis-2019-216095
Correspondence on ‘Standardisation of myositis-specific antibodies: where are we today?’
Maria Infantino, Mariangela Manfredi, Nicola Bizzaro

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e115; DOI: 10.1136/annrheumdis-2019-216217
Response to: ‘Comment on: standardisation of myositis-specific antibodies: where are we today?’ by Infantino et al
Johan Rönnelid, Fabricio Espinosa-Ortega, Ingrid E Lundberg

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e116; DOI: 10.1136/annrheumdis-2019-216248
Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies
Weng Ian Che, Helga Westerlind, Ingrid E Lundberg, Karin Hellgren, Ralf Kuja-Halkola, Marie Holmqvist

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-219914; DOI: 10.1136/annrheumdis-2021-219914
Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis
Naoko Okiyama, Yuki Ichimura, Miwako Shobo, Ryota Tanaka, Noriko Kubota, Akimasa Saito, Yosuke Ishitsuka, Rei Watanabe, Yasuhiro Fujisawa, Yoshiyuki Nakamura, Akihiro Murakami, Hisako Kayama, Kiyoshi Takeda, Manabu Fujimoto

Annals of the Rheumatic Diseases Apr 2021, annrheumdis-2020-218661; DOI: 10.1136/annrheumdis-2020-218661
Response to: ‘Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort’ by Costa et al
Latika Gupta, Durga Prasanna Misra, Vishwesh Agarwal, Suma Balan, Vikas Agarwal

Annals of the Rheumatic Diseases Apr 2021, 80 (4) e47; DOI: 10.1136/annrheumdis-2020-217953
Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis
Yuchuan Ding, Baozhen Huang, Yuan Wang, Jun Hou, Ying Chi, Zhixuan Zhou, Jianguo Li

Annals of the Rheumatic Diseases Apr 2021, 80 (4) 543-545; DOI: 10.1136/annrheumdis-2020-218582
Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis
Hanna Kim, Samantha Dill, Michelle O'Brien, Laura Vian, Xiaobai Li, Manuk Manukyan, Minal Jain, Lilian W Adeojo, Jomy George, Maria Perez, Alexei A Grom, Michelle Sutter, Brian M Feldman, Lawrence Yao, Michelle Millwood, April Brundidge, Dominique C Pichard, Edward W Cowen, Yinghui Shi, Shajia Lu, Wanxia Li Tsai, Massimo Gadina, Lisa G Rider, Robert A Colbert

Annals of the Rheumatic Diseases Mar 2021, 80 (3) 406-408; DOI: 10.1136/annrheumdis-2020-218690

Main menu

Dermatomyositis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Dermatomyositis

Pages